Fawaz Alzaïd

2.1k total citations
45 papers, 958 citations indexed

About

Fawaz Alzaïd is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Fawaz Alzaïd has authored 45 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Fawaz Alzaïd's work include Adipokines, Inflammation, and Metabolic Diseases (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and Adipose Tissue and Metabolism (7 papers). Fawaz Alzaïd is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (10 papers), Liver Disease Diagnosis and Treatment (7 papers) and Adipose Tissue and Metabolism (7 papers). Fawaz Alzaïd collaborates with scholars based in France, Kuwait and United Kingdom. Fawaz Alzaïd's co-authors include Nicolas Venteclef, Lucie Orliaguet, Karima Drareni, Victor R. Preedy, Paul Sharp, Élise Dalmas, Jean–François Gautier, Ronan Thibaut, Jean‐Pierre Riveline and Fatema Al‐Rashed and has published in prestigious journals such as Nature Medicine, PLoS ONE and Diabetes.

In The Last Decade

Fawaz Alzaïd

38 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fawaz Alzaïd France 15 383 262 192 182 136 45 958
Veena Dhawan India 20 348 0.9× 209 0.8× 245 1.3× 123 0.7× 97 0.7× 67 1.2k
Elsa Maymó‐Masip Spain 17 387 1.0× 254 1.0× 259 1.3× 242 1.3× 81 0.6× 39 983
Blanche C. Ip United States 17 252 0.7× 243 0.9× 160 0.8× 196 1.1× 85 0.6× 26 888
Irene O.C.M. Vroegrijk Netherlands 10 475 1.2× 391 1.5× 230 1.2× 204 1.1× 102 0.8× 10 1.0k
Gonzalo Álba Spain 16 374 1.0× 174 0.7× 187 1.0× 234 1.3× 112 0.8× 36 1.0k
Yanchuan Li China 23 523 1.4× 444 1.7× 310 1.6× 270 1.5× 243 1.8× 45 1.5k
Wenyan Lai China 20 561 1.5× 180 0.7× 148 0.8× 269 1.5× 150 1.1× 91 1.2k
Óscar Escribano Spain 19 454 1.2× 265 1.0× 92 0.5× 281 1.5× 152 1.1× 43 1.1k
Osamu Sekine Japan 18 415 1.1× 216 0.8× 149 0.8× 261 1.4× 192 1.4× 47 1.1k
Leela Goodspeed United States 16 318 0.8× 401 1.5× 183 1.0× 287 1.6× 167 1.2× 24 956

Countries citing papers authored by Fawaz Alzaïd

Since Specialization
Citations

This map shows the geographic impact of Fawaz Alzaïd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fawaz Alzaïd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fawaz Alzaïd more than expected).

Fields of papers citing papers by Fawaz Alzaïd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fawaz Alzaïd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fawaz Alzaïd. The network helps show where Fawaz Alzaïd may publish in the future.

Co-authorship network of co-authors of Fawaz Alzaïd

This figure shows the co-authorship network connecting the top 25 collaborators of Fawaz Alzaïd. A scholar is included among the top collaborators of Fawaz Alzaïd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fawaz Alzaïd. Fawaz Alzaïd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alzaïd, Fawaz, Hossein Arefanian, Anwar Mohammad, et al.. (2025). Unraveling the RKIP–YY1 axis: immune crosstalk in the pathogenesis of metabolic disorders. Frontiers in Immunology. 16. 1675699–1675699.
2.
Alzaïd, Fawaz, Guy Fagherazzi, Jean‐Pierre Riveline, et al.. (2025). Immune cell–adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes. Diabetologia. 68(8). 1616–1631. 8 indexed citations
3.
Gallo, Linda A., Katina D. Hulme, Fawaz Alzaïd, et al.. (2025). Measurement of serum 1,5-AG provides insights for diabetes management and the anti-viral immune response. Cellular and Molecular Life Sciences. 82(1). 71–71.
4.
Aguayo, Gloria, Emmanuel Cosson, Éric Renard, et al.. (2025). Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort. BMJ Open Diabetes Research & Care. 13(1). e004524–e004524. 1 indexed citations
5.
Al‐Rashed, Fatema, Hossein Arefanian, Ashraf Al Madhoun, et al.. (2024). Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation. Cells. 13(5). 463–463.
6.
Kochumon, Shihab, Hossein Arefanian, Fawaz Alzaïd, et al.. (2024). IL-1β-Induced CXCL10 Expression in THP-1 Monocytic Cells Involves the JNK/c-Jun and NF-κB-Mediated Signaling. Pharmaceuticals. 17(7). 823–823. 2 indexed citations
7.
Alzaïd, Fawaz, et al.. (2024). PPARdelta: A key modulator in the pathogenesis of diabetes mellitus and Mycobacterium tuberculosis co-morbidity. iScience. 27(7). 110046–110046. 3 indexed citations
8.
9.
Al‐Rashed, Fatema, et al.. (2023). Macrophages and the development and progression of non-alcoholic fatty liver disease. Frontiers in Immunology. 14. 1195699–1195699. 14 indexed citations
10.
Kochumon, Shihab, Amal Hasan, Fatema Al‐Rashed, et al.. (2022). Increased Adipose Tissue Expression of IL-23 Associates with Inflammatory Markers in People with High LDL Cholesterol. Cells. 11(19). 3072–3072. 14 indexed citations
11.
Hulme, Katina D., Ronan Thibaut, Jagadeesh Bayry, et al.. (2022). Respiratory Tract Infections in Diabetes – Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity. Frontiers in Endocrinology. 13. 919223–919223. 21 indexed citations
12.
Akhter, Nadeem, Shihab Kochumon, Amal Hasan, et al.. (2022). IFN-γ and LPS Induce Synergistic Expression of CCL2 in Monocytic Cells via H3K27 Acetylation. Journal of Inflammation Research. Volume 15. 4291–4302. 14 indexed citations
13.
Orliaguet, Lucie, Élise Dalmas, Karima Drareni, Nicolas Venteclef, & Fawaz Alzaïd. (2020). Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity. Frontiers in Endocrinology. 11. 62–62. 109 indexed citations
14.
Alzaïd, Fawaz, Jean‐Baptiste Julla, Marc Diedisheim, et al.. (2020). Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID ‐19 in type 2 diabetes. EMBO Molecular Medicine. 12(10). e13038–e13038. 37 indexed citations
15.
Orliaguet, Lucie, et al.. (2020). Metabolic and Molecular Mechanisms of Macrophage Polarisation and Adipose Tissue Insulin Resistance. International Journal of Molecular Sciences. 21(16). 5731–5731. 32 indexed citations
16.
Orliaguet, Lucie, Florence Castelli, François Fenaille, et al.. (2020). Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages. Annals of the Rheumatic Diseases. 79(11). 1506–1514. 117 indexed citations
17.
Brial, François, Lyamine Hedjazi, Jane Fearnside, et al.. (2019). Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. Scientific Reports. 9(1). 3656–3656. 10 indexed citations
18.
Drareni, Karima, Raphaëlle Ballaire, Amine Toubal, et al.. (2018). GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation. Cell Reports. 24(11). 2957–2971.e6. 39 indexed citations
19.
Oger, Frédérik, Céline Gheeraert, Julie Dubois‐Chevalier, et al.. (2017). The RBM14/CoAA-interacting, long intergenic non-coding RNA Paral1 regulates adipogenesis and coactivates the nuclear receptor PPARγ. Scientific Reports. 7(1). 14087–14087. 36 indexed citations
20.
Fan, Rongrong, Amine Toubal, Saioa Goñi, et al.. (2016). Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes. Nature Medicine. 22(7). 780–791. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Veena Dhawan Breakdown of academic impact, for papers by Elsa Maymó‐Masip Breakdown of academic impact, for papers by Blanche C. Ip Breakdown of academic impact, for papers by Irene O.C.M. Vroegrijk Breakdown of academic impact, for papers by Gonzalo Álba Breakdown of academic impact, for papers by Yanchuan Li Breakdown of academic impact, for papers by Wenyan Lai Breakdown of academic impact, for papers by Óscar Escribano Breakdown of academic impact, for papers by Osamu Sekine Breakdown of academic impact, for papers by Leela Goodspeed
Rankless by CCL
2026